Intrinsic Value of S&P & Nasdaq Contact Us

SAB Biotherapeutics, Inc. SABS

NASDAQ Global Market

SharesGrow Score
56/100
2/6 Pass
SharesGrow Intrinsic Value
$5.59
+44.8%
Analyst Price Target
$7.00
+81.3%

SAB Biotherapeutics, Inc. (SABS) current share price is $3.86. The gold spot price is $4,825.20 per troy ounce. Using the formula: SABS in gold = $3.86 × 31.1035 ÷ $4,825.20 = 0.0249 grams of gold per share.

The Real Wealth Growth Rate measures the Compound Annual Growth Rate (CAGR) of SABS when denominated in gold. A positive rate means the stock has outperformed gold as a store of value, while a negative rate indicates gold has been a better wealth preserver than holding SABS shares over the measured period.

SABS in US Dollars
Gold in US Dollars
SABS in Gold (grams per share)

Real Wealth Growth Rate

SABS
Computing…

"Real Wealth Growth Rate" measures the annualised compound growth rate (CAGR) of a stock when priced in gold — hard money that cannot be printed. A positive value means genuine wealth creation. A negative value means purchasing power is shrinking, even if the dollar price rises.

Step 1 — Express share price in grams of gold
$$\text{SABS}_{\text{gold}}(t) = \frac{P_{\text{SABS}}(t) \times 31.1035}{P_{\text{gold}}(t)}$$
$P_\text{SABS}$ = stock price in USD, $P_\text{gold}$ = gold spot in USD/troy oz, $31.1035$ = grams per troy ounce.
Step 2 — Real Wealth Growth Rate (CAGR in gold terms)
$$\text{Real Wealth Growth Rate} = \left(\frac{\text{SABS}_{\text{gold}}^{(T)}}{\text{SABS}_{\text{gold}}^{(0)}}\right)^{\!\frac{1}{T}} - 1$$
$\text{SABS}_\text{gold}^{(0)}$ = initial gold-price, $\text{SABS}_\text{gold}^{(T)}$ = current gold-price, $T$ = number of years. A positive result means the stock outpaces gold.

Real Wealth Growth Rate Rankings — 20 Years

Computing…

People Also View

MNPR
MNPR
Monopar Therapeutics Inc.
$57.92
+3.28%
THRD
THRD
Third Harmonic Bio, Inc.
$5.38
-0.09%
UNCY
UNCY
Unicycive Therapeutics, Inc.
$6.94
+4.83%
ANEB
ANEB
Anebulo Pharmaceuticals, Inc.
$0.50
-0.04%
CVKD
CVKD
Cadrenal Therapeutics, Inc. Common Stock
$4.79
-4.01%
PCSA
PCSA
Processa Pharmaceuticals, Inc.
$2.87
-0.35%
FRTX
FRTX
Fresh Tracks Therapeutics, Inc.
$0.94
-0.53%
QNRX
QNRX
Quoin Pharmaceuticals, Ltd.
$6.30
+6.42%
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
Send us a message